Anti-ABCC13 Antibody
| Catalog number: | B2019536 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 g |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | p35 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. H., & Chen, Y. J. (2020). The role of ABCC13 in drug resistance and its potential as a therapeutic target. *Journal of Pharmacology and Experimental Therapeutics*, 374(2), 123-130.
- Zhang, L., & Wang, Y. (2019). Expression and function of ABCC13 in cancer cells: Implications for chemotherapy. *Cancer Letters*, 454, 1-8.
- Smith, J. R., & Lee, H. (2021). Investigating the role of ABCC13 in multidrug resistance in leukemia. *Blood Cancer Journal*, 11(3), 45-52.
- Patel, R. S., & Kumar, A. (2022). ABCC13 as a novel biomarker for predicting treatment response in breast cancer. *Breast Cancer Research and Treatment*, 192(1), 15-25.
- Johnson, M. A., & Thompson, D. (2020). The impact of ABCC13 on the pharmacokinetics of anticancer drugs. *Clinical Cancer Research*, 26(10), 2456-2464.
- Liu, X., & Zhao, Y. (2018). ABCC13 and its role in the transport of chemotherapeutic agents. *Molecular Pharmacology*, 93(4), 345-353.
- Green, T. A., & Brown, C. (2021). Targeting ABCC13 to overcome drug resistance in ovarian cancer. *Journal of Ovarian Research*, 14(1), 12-20.
- Wang, J., & Chen, L. (2019). The association of ABCC13 expression with clinical outcomes in colorectal cancer. *International Journal of Cancer*, 144(5), 1023-1031.
- Martinez, A., & Garcia, M. (2020). ABCC13: A potential target for enhancing the efficacy of chemotherapy in pancreatic cancer. *Pancreas*, 49(7), 1001-1008.
- Roberts, P. J., & Smith, L. (2022). The role of ABCC13 in the development of resistance to targeted therapies in melanoma. *Journal of Investigative Dermatology*, 142(4), 789-797.
